

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NIK/NF-kappaB signaling (GO:0038061) | 7.63657496 |
| 2 | cilium or flagellum-dependent cell motility (GO:0001539) | 6.04338266 |
| 3 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 5.51453606 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.36793340 |
| 5 | axonemal dynein complex assembly (GO:0070286) | 5.26281658 |
| 6 | growth hormone receptor signaling pathway (GO:0060396) | 5.25464163 |
| 7 | motile cilium assembly (GO:0044458) | 4.65486881 |
| 8 | positive regulation of antigen processing and presentation (GO:0002579) | 4.58450047 |
| 9 | cellular response to growth hormone stimulus (GO:0071378) | 4.50291879 |
| 10 | regulation of RIG-I signaling pathway (GO:0039535) | 4.44845805 |
| 11 | myeloid dendritic cell differentiation (GO:0043011) | 4.38066257 |
| 12 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.36087922 |
| 13 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.16965646 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.16965646 |
| 15 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.11470393 |
| 16 | negative regulation of humoral immune response (GO:0002921) | 4.09598407 |
| 17 | T-helper 1 type immune response (GO:0042088) | 4.07272038 |
| 18 | regulation of hypersensitivity (GO:0002883) | 3.98448405 |
| 19 | cilium movement (GO:0003341) | 3.95838064 |
| 20 | dendritic cell differentiation (GO:0097028) | 3.89427068 |
| 21 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.85510239 |
| 22 | necroptotic process (GO:0070266) | 3.84472701 |
| 23 | positive regulation of interleukin-12 production (GO:0032735) | 3.83138729 |
| 24 | myeloid dendritic cell activation (GO:0001773) | 3.79031331 |
| 25 | negative regulation of protein activation cascade (GO:2000258) | 3.78347338 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 3.77203834 |
| 27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.75122585 |
| 28 | regulation of antigen processing and presentation (GO:0002577) | 3.73128966 |
| 29 | regulation of complement activation (GO:0030449) | 3.72618890 |
| 30 | negative regulation of complement activation (GO:0045916) | 3.71286734 |
| 31 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.70353222 |
| 32 | natural killer cell mediated immunity (GO:0002228) | 3.70353222 |
| 33 | regulation of protein activation cascade (GO:2000257) | 3.67392139 |
| 34 | neutrophil activation (GO:0042119) | 3.66142188 |
| 35 | leukocyte mediated cytotoxicity (GO:0001909) | 3.48056689 |
| 36 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.43057766 |
| 37 | regulation of natural killer cell differentiation (GO:0032823) | 3.41241967 |
| 38 | granulocyte activation (GO:0036230) | 3.40378837 |
| 39 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.40363374 |
| 40 | regulation of apoptotic cell clearance (GO:2000425) | 3.35784587 |
| 41 | response to muramyl dipeptide (GO:0032495) | 3.35746701 |
| 42 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.32015121 |
| 43 | protein carboxylation (GO:0018214) | 3.28602618 |
| 44 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.28602618 |
| 45 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.23918662 |
| 46 | T-helper cell differentiation (GO:0042093) | 3.23918662 |
| 47 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.18871712 |
| 48 | negative regulation of fibrinolysis (GO:0051918) | 3.18558594 |
| 49 | negative thymic T cell selection (GO:0045060) | 3.17022243 |
| 50 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.15411729 |
| 51 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.15334605 |
| 52 | cellular response to ethanol (GO:0071361) | 3.13976358 |
| 53 | carnitine transmembrane transport (GO:1902603) | 3.11937589 |
| 54 | regulation of skeletal muscle contraction (GO:0014819) | 3.11291762 |
| 55 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.09705629 |
| 56 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.09249734 |
| 57 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.05744724 |
| 58 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.05307848 |
| 59 | myeloid leukocyte mediated immunity (GO:0002444) | 3.02425858 |
| 60 | response to peptidoglycan (GO:0032494) | 3.00638657 |
| 61 | skeletal muscle adaptation (GO:0043501) | 2.99660527 |
| 62 | immunoglobulin mediated immune response (GO:0016064) | 2.98466334 |
| 63 | cytokine secretion (GO:0050663) | 2.97550995 |
| 64 | ethanol metabolic process (GO:0006067) | 2.96654683 |
| 65 | positive regulation of cholesterol efflux (GO:0010875) | 2.96423938 |
| 66 | intestinal cholesterol absorption (GO:0030299) | 2.95034007 |
| 67 | regulation of necroptotic process (GO:0060544) | 2.94816110 |
| 68 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.94372519 |
| 69 | regulation of T cell tolerance induction (GO:0002664) | 2.94024967 |
| 70 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.93706656 |
| 71 | positive regulation of extracellular matrix organization (GO:1903055) | 2.93570768 |
| 72 | positive regulation of natural killer cell activation (GO:0032816) | 2.92465695 |
| 73 | carnitine transport (GO:0015879) | 2.92424026 |
| 74 | amino-acid betaine transport (GO:0015838) | 2.92424026 |
| 75 | positive regulation of type 2 immune response (GO:0002830) | 2.90586601 |
| 76 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.90527185 |
| 77 | adenosine receptor signaling pathway (GO:0001973) | 2.90512932 |
| 78 | regulation of interleukin-12 production (GO:0032655) | 2.90224848 |
| 79 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.89957677 |
| 80 | iron ion import (GO:0097286) | 2.89489203 |
| 81 | epithelial cilium movement (GO:0003351) | 2.87692174 |
| 82 | axoneme assembly (GO:0035082) | 2.87483129 |
| 83 | cell killing (GO:0001906) | 2.86911544 |
| 84 | programmed necrotic cell death (GO:0097300) | 2.86303051 |
| 85 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.85393697 |
| 86 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.85227258 |
| 87 | macroautophagy (GO:0016236) | 2.84763296 |
| 88 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.83920785 |
| 89 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.83920785 |
| 90 | vitamin transmembrane transport (GO:0035461) | 2.83563865 |
| 91 | positive regulation of humoral immune response (GO:0002922) | 2.83504894 |
| 92 | negative T cell selection (GO:0043383) | 2.81981981 |
| 93 | primary alcohol catabolic process (GO:0034310) | 2.81672655 |
| 94 | positive regulation of neutrophil migration (GO:1902624) | 2.80792230 |
| 95 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.80792230 |
| 96 | regulation of activation of Janus kinase activity (GO:0010533) | 2.78429442 |
| 97 | response to fungus (GO:0009620) | 2.78260516 |
| 98 | ethanol oxidation (GO:0006069) | 2.76715104 |
| 99 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.76131429 |
| 100 | type I interferon signaling pathway (GO:0060337) | 2.75736839 |
| 101 | cellular response to type I interferon (GO:0071357) | 2.75736839 |
| 102 | striated muscle atrophy (GO:0014891) | 2.75481535 |
| 103 | positive regulation of cholesterol transport (GO:0032376) | 2.75250886 |
| 104 | positive regulation of sterol transport (GO:0032373) | 2.75250886 |
| 105 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.74816652 |
| 106 | necrotic cell death (GO:0070265) | 2.74648126 |
| 107 | response to type I interferon (GO:0034340) | 2.73970006 |
| 108 | positive regulation of interferon-alpha production (GO:0032727) | 2.73575927 |
| 109 | lung epithelium development (GO:0060428) | 2.73206239 |
| 110 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.71179483 |
| 111 | skeletal muscle contraction (GO:0003009) | 2.71095324 |
| 112 | neutrophil mediated immunity (GO:0002446) | 2.69890517 |
| 113 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.69863596 |
| 114 | regulation of fibrinolysis (GO:0051917) | 2.69316874 |
| 115 | dendritic cell migration (GO:0036336) | 2.67354945 |
| 116 | quaternary ammonium group transport (GO:0015697) | 2.67088998 |
| 117 | negative regulation of necroptotic process (GO:0060546) | 2.66905837 |
| 118 | T cell differentiation involved in immune response (GO:0002292) | 2.66622072 |
| 119 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.66622072 |
| 120 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.66622072 |
| 121 | glomerular epithelial cell development (GO:0072310) | 2.66609939 |
| 122 | hypotonic response (GO:0006971) | 2.66511523 |
| 123 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.65432131 |
| 124 | cholesterol efflux (GO:0033344) | 2.65037961 |
| 125 | carnitine shuttle (GO:0006853) | 2.64538903 |
| 126 | regulation of cellular extravasation (GO:0002691) | 2.64135442 |
| 127 | regulation of natural killer cell activation (GO:0032814) | 2.63740338 |
| 128 | myofibril assembly (GO:0030239) | 2.63591343 |
| 129 | mature B cell differentiation (GO:0002335) | 2.63172226 |
| 130 | complement activation, alternative pathway (GO:0006957) | 2.61167481 |
| 131 | dendritic cell chemotaxis (GO:0002407) | 2.60421698 |
| 132 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.59951972 |
| 133 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.59719426 |
| 134 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.59405527 |
| 135 | negative regulation of B cell mediated immunity (GO:0002713) | 2.59405527 |
| 136 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.59286548 |
| 137 | T cell activation involved in immune response (GO:0002286) | 2.58099652 |
| 138 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.57574940 |
| 139 | lymphocyte mediated immunity (GO:0002449) | 2.57260154 |
| 140 | plasma lipoprotein particle assembly (GO:0034377) | 2.56974369 |
| 141 | interferon-gamma secretion (GO:0072643) | 2.56493397 |
| 142 | positive regulation of p38MAPK cascade (GO:1900745) | 2.56239304 |
| 143 | low-density lipoprotein particle remodeling (GO:0034374) | 2.55256963 |
| 144 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.53535028 |
| 145 | positive regulation of macrophage cytokine production (GO:0060907) | 2.52031853 |
| 146 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.50283350 |
| 147 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.49903450 |
| 148 | regulation of interferon-alpha production (GO:0032647) | 2.49886551 |
| 149 | detection of molecule of bacterial origin (GO:0032490) | 2.49672605 |
| 150 | negative regulation of cell killing (GO:0031342) | 2.49592986 |
| 151 | protein-lipid complex assembly (GO:0065005) | 2.48614588 |
| 152 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.48428446 |
| 153 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.47222469 |
| 154 | fatty acid transmembrane transport (GO:1902001) | 2.47091223 |
| 155 | protein-lipid complex remodeling (GO:0034368) | 2.46211356 |
| 156 | macromolecular complex remodeling (GO:0034367) | 2.46211356 |
| 157 | plasma lipoprotein particle remodeling (GO:0034369) | 2.46211356 |
| 158 | germinal center formation (GO:0002467) | 2.43660393 |
| 159 | regulation of humoral immune response (GO:0002920) | 2.40931841 |
| 160 | diterpenoid biosynthetic process (GO:0016102) | 2.40484769 |
| 161 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.40227576 |
| 162 | regulation of alkaline phosphatase activity (GO:0010692) | 2.39698321 |
| 163 | plasma lipoprotein particle organization (GO:0071827) | 2.39171792 |
| 164 | protein-lipid complex subunit organization (GO:0071825) | 2.35690856 |
| 165 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.35665436 |
| 166 | interkinetic nuclear migration (GO:0022027) | 2.32948066 |
| 167 | high-density lipoprotein particle remodeling (GO:0034375) | 2.31225640 |
| 168 | muscle atrophy (GO:0014889) | 2.30655143 |
| 169 | regulation of cholesterol homeostasis (GO:2000188) | 2.29771924 |
| 170 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.29351158 |
| 171 | acute-phase response (GO:0006953) | 2.28656215 |
| 172 | oligosaccharide catabolic process (GO:0009313) | 2.28389446 |
| 173 | actin-myosin filament sliding (GO:0033275) | 2.27579886 |
| 174 | muscle filament sliding (GO:0030049) | 2.27579886 |
| 175 | response to muscle activity (GO:0014850) | 2.26494356 |
| 176 | fibrinolysis (GO:0042730) | 2.26475229 |
| 177 | desmosome organization (GO:0002934) | 2.25848336 |
| 178 | regulation of germinal center formation (GO:0002634) | 2.25841924 |
| 179 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.25541192 |
| 180 | cardiac myofibril assembly (GO:0055003) | 2.24946277 |
| 181 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.21719764 |
| 182 | lipoprotein metabolic process (GO:0042157) | 2.20860092 |
| 183 | flavonoid metabolic process (GO:0009812) | 2.19306018 |
| 184 | positive regulation of hemostasis (GO:1900048) | 2.19022287 |
| 185 | positive regulation of blood coagulation (GO:0030194) | 2.19022287 |
| 186 | sarcomere organization (GO:0045214) | 2.17834839 |
| 187 | glycogen catabolic process (GO:0005980) | 2.16769264 |
| 188 | reverse cholesterol transport (GO:0043691) | 2.16708696 |
| 189 | positive regulation of coagulation (GO:0050820) | 2.16637717 |
| 190 | plasma lipoprotein particle clearance (GO:0034381) | 2.15361592 |
| 191 | mannose metabolic process (GO:0006013) | 2.14615163 |
| 192 | pinocytosis (GO:0006907) | 2.13001806 |
| 193 | negative regulation of TOR signaling (GO:0032007) | 2.12407101 |
| 194 | positive regulation of chemokine secretion (GO:0090197) | 2.10669078 |
| 195 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.10584902 |
| 196 | phospholipid efflux (GO:0033700) | 2.10536664 |
| 197 | regulation of chemokine secretion (GO:0090196) | 2.10260980 |
| 198 | exogenous drug catabolic process (GO:0042738) | 2.09498642 |
| 199 | drug catabolic process (GO:0042737) | 2.07953841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.22077739 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.00861249 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.21732160 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.16449931 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.09853849 |
| 6 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.07081233 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.05265740 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.03045397 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 3.02648444 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.97663707 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.80340064 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.69386650 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42373598 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.41321151 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.39663944 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.36475340 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.34233453 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.30061035 |
| 19 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.18830818 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.10601602 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.10296361 |
| 22 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.07602346 |
| 23 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.92096614 |
| 24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.91245163 |
| 25 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.90921488 |
| 26 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.90347579 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.77893708 |
| 28 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.77374206 |
| 29 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.72635947 |
| 30 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.66829166 |
| 31 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.63414092 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.62039803 |
| 33 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59414593 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.58664269 |
| 35 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.58242335 |
| 36 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54082153 |
| 37 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.53325007 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.51254825 |
| 39 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.48677745 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46160402 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 1.45994456 |
| 42 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.44604667 |
| 43 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.44062768 |
| 44 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.44038163 |
| 45 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.39215052 |
| 46 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.37444548 |
| 47 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.37444548 |
| 48 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.35318770 |
| 49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.35106610 |
| 50 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.31778561 |
| 51 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31135373 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31085262 |
| 53 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.31070373 |
| 54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30623614 |
| 55 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26211718 |
| 56 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.25962612 |
| 57 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.25906386 |
| 58 | MYB_26560356_Chip-Seq_TH2_Human | 1.25647566 |
| 59 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24836521 |
| 60 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.23169412 |
| 61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.22880483 |
| 62 | MYB_26560356_Chip-Seq_TH1_Human | 1.22705797 |
| 63 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.22129884 |
| 64 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22011039 |
| 65 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.21433302 |
| 66 | TP53_16413492_ChIP-PET_HCT116_Human | 1.19778912 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19125209 |
| 68 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.17185981 |
| 69 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.17185981 |
| 70 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.16687165 |
| 71 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.15910578 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.15868853 |
| 73 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15808047 |
| 74 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.14307104 |
| 75 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13057574 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13041180 |
| 77 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.12733970 |
| 78 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12509392 |
| 79 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11510333 |
| 80 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.10916643 |
| 81 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09599635 |
| 82 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08598702 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08329050 |
| 84 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.08223983 |
| 85 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.07681249 |
| 86 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.07427891 |
| 87 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.06511685 |
| 88 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04905915 |
| 89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04784741 |
| 90 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02821543 |
| 91 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.02816540 |
| 92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02225895 |
| 93 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02058469 |
| 94 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.01604869 |
| 95 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.01524492 |
| 96 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01043676 |
| 97 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00941969 |
| 98 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00008612 |
| 99 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98370059 |
| 100 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97741069 |
| 101 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97453437 |
| 102 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96151245 |
| 103 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.96041049 |
| 104 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95681377 |
| 105 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95446600 |
| 106 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93506457 |
| 107 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93506457 |
| 108 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92372179 |
| 109 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.92035711 |
| 110 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91510186 |
| 111 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90677243 |
| 112 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89724171 |
| 113 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.88954976 |
| 114 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88815698 |
| 115 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.88677146 |
| 116 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88218622 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88034655 |
| 118 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88019994 |
| 119 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.87987076 |
| 120 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87388346 |
| 121 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.86978034 |
| 122 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86412630 |
| 123 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86194121 |
| 124 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86015087 |
| 125 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.85361375 |
| 126 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.84795069 |
| 127 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84092299 |
| 128 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.82460570 |
| 129 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82319002 |
| 130 | UTX_26944678_Chip-Seq_JUKART_Human | 0.82201378 |
| 131 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81403570 |
| 132 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80869954 |
| 133 | RXR_22108803_ChIP-Seq_LS180_Human | 0.79223732 |
| 134 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77925540 |
| 135 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76717693 |
| 136 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76639622 |
| 137 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74703563 |
| 138 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.74507875 |
| 139 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.72919805 |
| 140 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.71860747 |
| 141 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71549318 |
| 142 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71538948 |
| 143 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.71299858 |
| 144 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.70897903 |
| 145 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.70506277 |
| 146 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.70198385 |
| 147 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.69771096 |
| 148 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.69731401 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 6.06533542 |
| 2 | MP0002138_abnormal_hepatobiliary_system | 5.22554059 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.12875378 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.51281781 |
| 5 | MP0000685_abnormal_immune_system | 3.41264861 |
| 6 | MP0004510_myositis | 3.33353792 |
| 7 | MP0000569_abnormal_digit_pigmentation | 3.27423038 |
| 8 | MP0001348_abnormal_lacrimal_gland | 3.04023806 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 3.02028070 |
| 10 | MP0005310_abnormal_salivary_gland | 2.97495205 |
| 11 | MP0001346_abnormal_lacrimal_gland | 2.80739859 |
| 12 | MP0003195_calcinosis | 2.78907559 |
| 13 | MP0005451_abnormal_body_composition | 2.77021286 |
| 14 | MP0002877_abnormal_melanocyte_morpholog | 2.64755639 |
| 15 | MP0002166_altered_tumor_susceptibility | 2.61972478 |
| 16 | MP0003646_muscle_fatigue | 2.54562694 |
| 17 | MP0003436_decreased_susceptibility_to | 2.53307523 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.46324490 |
| 19 | MP0005387_immune_system_phenotype | 2.26628029 |
| 20 | MP0001790_abnormal_immune_system | 2.26628029 |
| 21 | MP0001873_stomach_inflammation | 2.25033057 |
| 22 | MP0000751_myopathy | 2.22255919 |
| 23 | MP0004036_abnormal_muscle_relaxation | 2.21844236 |
| 24 | MP0002009_preneoplasia | 2.19707637 |
| 25 | MP0003303_peritoneal_inflammation | 2.19196723 |
| 26 | MP0009785_altered_susceptibility_to | 2.16504377 |
| 27 | MP0004084_abnormal_cardiac_muscle | 2.15066166 |
| 28 | MP0003950_abnormal_plasma_membrane | 2.10357773 |
| 29 | MP0002006_tumorigenesis | 2.02231601 |
| 30 | MP0002419_abnormal_innate_immunity | 2.01583412 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 2.00737631 |
| 32 | MP0003828_pulmonary_edema | 1.98754180 |
| 33 | MP0002163_abnormal_gland_morphology | 1.96305139 |
| 34 | MP0003183_abnormal_peptide_metabolism | 1.93380409 |
| 35 | MP0004130_abnormal_muscle_cell | 1.91622975 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.90280318 |
| 37 | MP0005671_abnormal_response_to | 1.88748866 |
| 38 | MP0005000_abnormal_immune_tolerance | 1.84413744 |
| 39 | MP0001800_abnormal_humoral_immune | 1.84398050 |
| 40 | MP0004043_abnormal_pH_regulation | 1.83973027 |
| 41 | MP0005330_cardiomyopathy | 1.82052112 |
| 42 | MP0005025_abnormal_response_to | 1.81424354 |
| 43 | MP0002332_abnormal_exercise_endurance | 1.80712332 |
| 44 | MP0002452_abnormal_antigen_presenting | 1.73907594 |
| 45 | MP0002277_abnormal_respiratory_mucosa | 1.72028544 |
| 46 | MP0000749_muscle_degeneration | 1.67527444 |
| 47 | MP0002723_abnormal_immune_serum | 1.66501996 |
| 48 | MP0002132_abnormal_respiratory_system | 1.64418419 |
| 49 | MP0010234_abnormal_vibrissa_follicle | 1.63310736 |
| 50 | MP0002168_other_aberrant_phenotype | 1.62672057 |
| 51 | MP0001819_abnormal_immune_cell | 1.57691428 |
| 52 | MP0001881_abnormal_mammary_gland | 1.57163273 |
| 53 | MP0004233_abnormal_muscle_weight | 1.53695815 |
| 54 | MP0005670_abnormal_white_adipose | 1.53364684 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.53019986 |
| 56 | MP0003300_gastrointestinal_ulcer | 1.52944760 |
| 57 | MP0002420_abnormal_adaptive_immunity | 1.52566997 |
| 58 | MP0004087_abnormal_muscle_fiber | 1.47973701 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.47283208 |
| 60 | MP0001666_abnormal_nutrient_absorption | 1.45915761 |
| 61 | MP0010329_abnormal_lipoprotein_level | 1.39207106 |
| 62 | MP0009764_decreased_sensitivity_to | 1.36166936 |
| 63 | MP0010155_abnormal_intestine_physiology | 1.36152630 |
| 64 | MP0005464_abnormal_platelet_physiology | 1.35509264 |
| 65 | MP0010368_abnormal_lymphatic_system | 1.33400488 |
| 66 | MP0009840_abnormal_foam_cell | 1.31916635 |
| 67 | MP0003045_fibrosis | 1.31128617 |
| 68 | MP0000747_muscle_weakness | 1.31086663 |
| 69 | MP0002405_respiratory_system_inflammati | 1.30638266 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 1.30574135 |
| 71 | MP0005379_endocrine/exocrine_gland_phen | 1.29813654 |
| 72 | MP0005360_urolithiasis | 1.27904157 |
| 73 | MP0004484_altered_response_of | 1.26320722 |
| 74 | MP0005174_abnormal_tail_pigmentation | 1.26084421 |
| 75 | MP0002822_catalepsy | 1.25592455 |
| 76 | MP0005058_abnormal_lysosome_morphology | 1.25193093 |
| 77 | MP0005409_darkened_coat_color | 1.22314605 |
| 78 | MP0001853_heart_inflammation | 1.21245586 |
| 79 | MP0001845_abnormal_inflammatory_respons | 1.20942003 |
| 80 | MP0002269_muscular_atrophy | 1.20707080 |
| 81 | MP0005551_abnormal_eye_electrophysiolog | 1.20355180 |
| 82 | MP0003252_abnormal_bile_duct | 1.20241475 |
| 83 | MP0003011_delayed_dark_adaptation | 1.19876902 |
| 84 | MP0000716_abnormal_immune_system | 1.18984598 |
| 85 | MP0003566_abnormal_cell_adhesion | 1.18635233 |
| 86 | MP0005164_abnormal_response_to | 1.18526339 |
| 87 | MP0001661_extended_life_span | 1.18291437 |
| 88 | MP0003075_altered_response_to | 1.17730601 |
| 89 | MP0004947_skin_inflammation | 1.16756856 |
| 90 | MP0010678_abnormal_skin_adnexa | 1.16561473 |
| 91 | MP0002837_dystrophic_cardiac_calcinosis | 1.15079586 |
| 92 | MP0002106_abnormal_muscle_physiology | 1.14563607 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 1.14074579 |
| 94 | MP0002118_abnormal_lipid_homeostasis | 1.13356572 |
| 95 | MP0006138_congestive_heart_failure | 1.12780323 |
| 96 | MP0004145_abnormal_muscle_electrophysio | 1.11678014 |
| 97 | MP0010630_abnormal_cardiac_muscle | 1.11273570 |
| 98 | MP0000383_abnormal_hair_follicle | 1.10619814 |
| 99 | MP0003724_increased_susceptibility_to | 1.10263914 |
| 100 | MP0005076_abnormal_cell_differentiation | 1.10036801 |
| 101 | MP0002971_abnormal_brown_adipose | 1.08854573 |
| 102 | MP0002972_abnormal_cardiac_muscle | 1.08829251 |
| 103 | MP0002928_abnormal_bile_duct | 1.08437939 |
| 104 | MP0002398_abnormal_bone_marrow | 1.08229976 |
| 105 | MP0002998_abnormal_bone_remodeling | 1.02182848 |
| 106 | MP0003879_abnormal_hair_cell | 1.01258117 |
| 107 | MP0005397_hematopoietic_system_phenotyp | 1.00253990 |
| 108 | MP0001545_abnormal_hematopoietic_system | 1.00253990 |
| 109 | MP0001533_abnormal_skeleton_physiology | 0.99638519 |
| 110 | MP0004215_abnormal_myocardial_fiber | 0.98614467 |
| 111 | MP0005620_abnormal_muscle_contractility | 0.97201606 |
| 112 | MP0005375_adipose_tissue_phenotype | 0.96474150 |
| 113 | MP0001756_abnormal_urination | 0.96126646 |
| 114 | MP0004782_abnormal_surfactant_physiolog | 0.95697967 |
| 115 | MP0002693_abnormal_pancreas_physiology | 0.95531799 |
| 116 | MP0005666_abnormal_adipose_tissue | 0.94688424 |
| 117 | MP0009278_abnormal_bone_marrow | 0.93680034 |
| 118 | MP0005083_abnormal_biliary_tract | 0.93135939 |
| 119 | MP0000609_abnormal_liver_physiology | 0.91546178 |
| 120 | MP0008260_abnormal_autophagy | 0.91300208 |
| 121 | MP0008469_abnormal_protein_level | 0.90741919 |
| 122 | MP0006082_CNS_inflammation | 0.90714881 |
| 123 | MP0000759_abnormal_skeletal_muscle | 0.89219205 |
| 124 | MP0000013_abnormal_adipose_tissue | 0.89081203 |
| 125 | MP0004883_abnormal_blood_vessel | 0.88638726 |
| 126 | MP0005332_abnormal_amino_acid | 0.87753329 |
| 127 | MP0003448_altered_tumor_morphology | 0.86002299 |
| 128 | MP0000003_abnormal_adipose_tissue | 0.85966754 |
| 129 | MP0002429_abnormal_blood_cell | 0.85827332 |
| 130 | MP0005023_abnormal_wound_healing | 0.85311356 |
| 131 | MP0005165_increased_susceptibility_to | 0.84730580 |
| 132 | MP0003868_abnormal_feces_composition | 0.84660019 |
| 133 | MP0004019_abnormal_vitamin_homeostasis | 0.84380784 |
| 134 | MP0003690_abnormal_glial_cell | 0.84315940 |
| 135 | MP0009643_abnormal_urine_homeostasis | 0.84209355 |
| 136 | MP0005376_homeostasis/metabolism_phenot | 0.83833538 |
| 137 | MP0009115_abnormal_fat_cell | 0.83750032 |
| 138 | MP0005085_abnormal_gallbladder_physiolo | 0.83628668 |
| 139 | MP0005369_muscle_phenotype | 0.82154462 |
| 140 | MP0000604_amyloidosis | 0.82060213 |
| 141 | MP0002090_abnormal_vision | 0.82051948 |
| 142 | MP0001851_eye_inflammation | 0.81684630 |
| 143 | MP0001765_abnormal_ion_homeostasis | 0.81409800 |
| 144 | MP0005319_abnormal_enzyme/_coenzyme | 0.81316842 |
| 145 | MP0005167_abnormal_blood-brain_barrier | 0.80819276 |
| 146 | MP0001879_abnormal_lymphatic_vessel | 0.80439720 |
| 147 | MP0006054_spinal_hemorrhage | 0.79974985 |
| 148 | MP0005266_abnormal_metabolism | 0.79344935 |
| 149 | MP0008872_abnormal_physiological_respon | 0.78155241 |
| 150 | MP0003763_abnormal_thymus_physiology | 0.78110284 |
| 151 | MP0010352_gastrointestinal_tract_polyps | 0.75140767 |
| 152 | MP0000371_diluted_coat_color | 0.70094731 |
| 153 | MP0003787_abnormal_imprinting | 0.69726024 |
| 154 | MP0002722_abnormal_immune_system | 0.69414589 |
| 155 | MP0005365_abnormal_bile_salt | 0.65557834 |
| 156 | MP0004264_abnormal_extraembryonic_tissu | 0.64409935 |
| 157 | MP0000689_abnormal_spleen_morphology | 0.63774462 |
| 158 | MP0000858_altered_metastatic_potential | 0.63441274 |
| 159 | MP0000767_abnormal_smooth_muscle | 0.62705224 |
| 160 | MP0010307_abnormal_tumor_latency | 0.61338770 |
| 161 | MP0005253_abnormal_eye_physiology | 0.60545355 |
| 162 | MP0000627_abnormal_mammary_gland | 0.58686913 |
| 163 | MP0003091_abnormal_cell_migration | 0.58150114 |
| 164 | MP0009765_abnormal_xenobiotic_induced | 0.57177357 |
| 165 | MP0004808_abnormal_hematopoietic_stem | 0.56645529 |
| 166 | MP0002909_abnormal_adrenal_gland | 0.56418671 |
| 167 | MP0005084_abnormal_gallbladder_morpholo | 0.55820484 |
| 168 | MP0003705_abnormal_hypodermis_morpholog | 0.55788807 |
| 169 | MP0000249_abnormal_blood_vessel | 0.54118715 |
| 170 | MP0001663_abnormal_digestive_system | 0.53955281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.97072475 |
| 2 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.61896235 |
| 3 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 5.36295759 |
| 4 | Absent/shortened dynein arms (HP:0200106) | 5.36295759 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.20973141 |
| 6 | Abnormal ciliary motility (HP:0012262) | 5.16574567 |
| 7 | Abnormal respiratory motile cilium morphology (HP:0005938) | 5.12809581 |
| 8 | Abnormal respiratory epithelium morphology (HP:0012253) | 5.12809581 |
| 9 | Abnormal respiratory motile cilium physiology (HP:0012261) | 5.01319630 |
| 10 | Recurrent abscess formation (HP:0002722) | 4.86096503 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.81390161 |
| 12 | Rhinitis (HP:0012384) | 4.61949607 |
| 13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.55743336 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.28596806 |
| 15 | Colitis (HP:0002583) | 4.25055317 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 4.16517866 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.16517866 |
| 18 | Deep venous thrombosis (HP:0002625) | 4.07892412 |
| 19 | Congenital stationary night blindness (HP:0007642) | 4.06560777 |
| 20 | Increased IgE level (HP:0003212) | 3.94607009 |
| 21 | Chronic bronchitis (HP:0004469) | 3.91084846 |
| 22 | Autoimmune thrombocytopenia (HP:0001973) | 3.87824406 |
| 23 | Recurrent skin infections (HP:0001581) | 3.81680216 |
| 24 | Recurrent viral infections (HP:0004429) | 3.78190527 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 3.77230369 |
| 26 | Fatigue (HP:0012378) | 3.75409879 |
| 27 | Periodontitis (HP:0000704) | 3.64566923 |
| 28 | Myocardial infarction (HP:0001658) | 3.63358957 |
| 29 | Hematochezia (HP:0002573) | 3.57352219 |
| 30 | Myositis (HP:0100614) | 3.57287478 |
| 31 | Pigmentary retinal degeneration (HP:0001146) | 3.55550591 |
| 32 | Orchitis (HP:0100796) | 3.54498478 |
| 33 | Bronchiectasis (HP:0002110) | 3.52100461 |
| 34 | Exercise-induced myalgia (HP:0003738) | 3.49783675 |
| 35 | Retrobulbar optic neuritis (HP:0100654) | 3.44792642 |
| 36 | Optic neuritis (HP:0100653) | 3.44792642 |
| 37 | Inflammation of the large intestine (HP:0002037) | 3.31711884 |
| 38 | Gingivitis (HP:0000230) | 3.31313253 |
| 39 | Prolonged partial thromboplastin time (HP:0003645) | 3.29276418 |
| 40 | Abnormality of macrophages (HP:0004311) | 3.21905081 |
| 41 | Hemorrhage of the eye (HP:0011885) | 3.21658959 |
| 42 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.19697073 |
| 43 | Polycythemia (HP:0001901) | 3.18795302 |
| 44 | Muscle fiber inclusion bodies (HP:0100299) | 3.18624238 |
| 45 | Arterial thrombosis (HP:0004420) | 3.18281835 |
| 46 | Nemaline bodies (HP:0003798) | 3.16596250 |
| 47 | Joint hemorrhage (HP:0005261) | 3.14794102 |
| 48 | Interstitial pulmonary disease (HP:0006530) | 3.14013230 |
| 49 | Complement deficiency (HP:0004431) | 3.13315744 |
| 50 | Gastrointestinal inflammation (HP:0004386) | 3.13070255 |
| 51 | Muscle fiber splitting (HP:0003555) | 3.08483853 |
| 52 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.08428626 |
| 53 | Hyperkalemia (HP:0002153) | 3.04010402 |
| 54 | Esophageal varix (HP:0002040) | 2.93666816 |
| 55 | Pulmonary infiltrates (HP:0002113) | 2.90274001 |
| 56 | Flat acetabular roof (HP:0003180) | 2.90202612 |
| 57 | Glomerulonephritis (HP:0000099) | 2.88145933 |
| 58 | Keratoconjunctivitis (HP:0001096) | 2.86609365 |
| 59 | Thrombocytosis (HP:0001894) | 2.83181142 |
| 60 | Asymmetric septal hypertrophy (HP:0001670) | 2.82371386 |
| 61 | Distal lower limb muscle weakness (HP:0009053) | 2.79727451 |
| 62 | Cortical dysplasia (HP:0002539) | 2.77847130 |
| 63 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.75645188 |
| 64 | Macular degeneration (HP:0000608) | 2.74886778 |
| 65 | Abnormality of the fingertips (HP:0001211) | 2.72238193 |
| 66 | Chronic otitis media (HP:0000389) | 2.70946632 |
| 67 | Increased IgM level (HP:0003496) | 2.66313507 |
| 68 | Gingival bleeding (HP:0000225) | 2.64067461 |
| 69 | Eosinophilia (HP:0001880) | 2.60851759 |
| 70 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.60675383 |
| 71 | Gastrointestinal infarctions (HP:0005244) | 2.59802559 |
| 72 | Progressive visual loss (HP:0000529) | 2.53967275 |
| 73 | Increased cerebral lipofuscin (HP:0011813) | 2.53567859 |
| 74 | Posterior subcapsular cataract (HP:0007787) | 2.48695400 |
| 75 | Hypergammaglobulinemia (HP:0010702) | 2.48385846 |
| 76 | Vascular calcification (HP:0004934) | 2.46831104 |
| 77 | Dysmetric saccades (HP:0000641) | 2.45379146 |
| 78 | Abnormality of the common coagulation pathway (HP:0010990) | 2.44882548 |
| 79 | Chorioretinal atrophy (HP:0000533) | 2.39040429 |
| 80 | Mucopolysacchariduria (HP:0008155) | 2.38203667 |
| 81 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.38203667 |
| 82 | Central scotoma (HP:0000603) | 2.36479562 |
| 83 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.36297673 |
| 84 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.36297673 |
| 85 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.36297673 |
| 86 | Vasculitis (HP:0002633) | 2.36229852 |
| 87 | Panhypogammaglobulinemia (HP:0003139) | 2.35715346 |
| 88 | Abnormality of the gastric mucosa (HP:0004295) | 2.33556905 |
| 89 | Male infertility (HP:0003251) | 2.33497667 |
| 90 | Abnormality of complement system (HP:0005339) | 2.31113646 |
| 91 | Chest pain (HP:0100749) | 2.27939263 |
| 92 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.26728825 |
| 93 | Agammaglobulinemia (HP:0004432) | 2.26497448 |
| 94 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.25726935 |
| 95 | Abolished electroretinogram (ERG) (HP:0000550) | 2.23730040 |
| 96 | Hyperactive renin-angiotensin system (HP:0000841) | 2.22251495 |
| 97 | Abnormality of the calf musculature (HP:0001430) | 2.21773951 |
| 98 | Hypobetalipoproteinemia (HP:0003563) | 2.21610267 |
| 99 | Malnutrition (HP:0004395) | 2.19299874 |
| 100 | Tetraparesis (HP:0002273) | 2.19025593 |
| 101 | Meningitis (HP:0001287) | 2.17420470 |
| 102 | Autoimmune hemolytic anemia (HP:0001890) | 2.17144502 |
| 103 | Popliteal pterygium (HP:0009756) | 2.17059864 |
| 104 | Keratoconjunctivitis sicca (HP:0001097) | 2.16906040 |
| 105 | Hyporeflexia of lower limbs (HP:0002600) | 2.16749453 |
| 106 | Difficulty running (HP:0009046) | 2.16437909 |
| 107 | Recurrent sinusitis (HP:0011108) | 2.15720265 |
| 108 | Albinism (HP:0001022) | 2.14746291 |
| 109 | Granulocytopenia (HP:0001913) | 2.13865830 |
| 110 | Portal hypertension (HP:0001409) | 2.12784518 |
| 111 | Obstructive lung disease (HP:0006536) | 2.12667843 |
| 112 | Chronic obstructive pulmonary disease (HP:0006510) | 2.12667843 |
| 113 | Urticaria (HP:0001025) | 2.11674089 |
| 114 | Type 1 muscle fiber predominance (HP:0003803) | 2.10967227 |
| 115 | EMG: myopathic abnormalities (HP:0003458) | 2.10296290 |
| 116 | Facial diplegia (HP:0001349) | 2.10041441 |
| 117 | Cellulitis (HP:0100658) | 2.09832310 |
| 118 | Viral hepatitis (HP:0006562) | 2.07665947 |
| 119 | Leukocytosis (HP:0001974) | 2.07486566 |
| 120 | Hemoptysis (HP:0002105) | 2.07210554 |
| 121 | Right ventricular cardiomyopathy (HP:0011663) | 2.07000668 |
| 122 | Hypolipoproteinemia (HP:0010981) | 2.05559317 |
| 123 | Cardiovascular calcification (HP:0011915) | 2.03657254 |
| 124 | Cone-rod dystrophy (HP:0000548) | 2.02891727 |
| 125 | Polygenic inheritance (HP:0010982) | 2.02440807 |
| 126 | Bundle branch block (HP:0011710) | 2.01845832 |
| 127 | Infertility (HP:0000789) | 2.00937092 |
| 128 | Abnormality of the hepatic vasculature (HP:0006707) | 2.00217274 |
| 129 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.99833544 |
| 130 | Subcapsular cataract (HP:0000523) | 1.99045864 |
| 131 | Recurrent otitis media (HP:0000403) | 1.98957469 |
| 132 | Porencephaly (HP:0002132) | 1.97486307 |
| 133 | Nephritis (HP:0000123) | 1.96027811 |
| 134 | Thyroiditis (HP:0100646) | 1.95996659 |
| 135 | Hypoalphalipoproteinemia (HP:0003233) | 1.95296984 |
| 136 | Xanthomatosis (HP:0000991) | 1.94557114 |
| 137 | Dysostosis multiplex (HP:0000943) | 1.94335770 |
| 138 | Systemic lupus erythematosus (HP:0002725) | 1.93374855 |
| 139 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.92687524 |
| 140 | Abnormality of the nasal mucosa (HP:0000433) | 1.92606025 |
| 141 | Encephalitis (HP:0002383) | 1.92569475 |
| 142 | Amaurosis fugax (HP:0100576) | 1.92394818 |
| 143 | Thrombophlebitis (HP:0004418) | 1.91928998 |
| 144 | Lip pit (HP:0100267) | 1.91612296 |
| 145 | Mitral stenosis (HP:0001718) | 1.91524685 |
| 146 | Skin nodule (HP:0200036) | 1.90938017 |
| 147 | Abnormality of eosinophils (HP:0001879) | 1.90229059 |
| 148 | Papillary thyroid carcinoma (HP:0002895) | 1.89320045 |
| 149 | Nasal polyposis (HP:0100582) | 1.87417631 |
| 150 | Bronchitis (HP:0012387) | 1.87257458 |
| 151 | Increased connective tissue (HP:0009025) | 1.86115639 |
| 152 | Abnormality of glycolipid metabolism (HP:0010969) | 1.85068437 |
| 153 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.85068437 |
| 154 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.85068437 |
| 155 | Calf muscle hypertrophy (HP:0008981) | 1.84093953 |
| 156 | Frequent falls (HP:0002359) | 1.84074760 |
| 157 | Hypercholesterolemia (HP:0003124) | 1.83642647 |
| 158 | Abnormality of macular pigmentation (HP:0008002) | 1.81861270 |
| 159 | Purpura (HP:0000979) | 1.81230152 |
| 160 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.81145066 |
| 161 | Spontaneous hematomas (HP:0007420) | 1.80881070 |
| 162 | Villous atrophy (HP:0011473) | 1.80725156 |
| 163 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.80725156 |
| 164 | Amyloidosis (HP:0011034) | 1.80232719 |
| 165 | Abnormality of the periventricular white matter (HP:0002518) | 1.79155422 |
| 166 | Cerebral ischemia (HP:0002637) | 1.78864375 |
| 167 | Premature loss of primary teeth (HP:0006323) | 1.78047884 |
| 168 | Cerebral aneurysm (HP:0004944) | 1.75574395 |
| 169 | Photophobia (HP:0000613) | 1.75497145 |
| 170 | Menorrhagia (HP:0000132) | 1.75033161 |
| 171 | Abnormality of T cell physiology (HP:0011840) | 1.74125614 |
| 172 | Sudden death (HP:0001699) | 1.72827771 |
| 173 | Ulnar deviation of the wrist (HP:0003049) | 1.72744144 |
| 174 | Acute myeloid leukemia (HP:0004808) | 1.72481048 |
| 175 | Decreased circulating renin level (HP:0003351) | 1.72266520 |
| 176 | Epistaxis (HP:0000421) | 1.71695053 |
| 177 | Diaphragmatic weakness (HP:0009113) | 1.71399733 |
| 178 | Decreased central vision (HP:0007663) | 1.71339036 |
| 179 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.71035422 |
| 180 | Pendular nystagmus (HP:0012043) | 1.70960145 |
| 181 | Abnormality of the nasal septum (HP:0000419) | 1.70631926 |
| 182 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.69874147 |
| 183 | Subaortic stenosis (HP:0001682) | 1.69874147 |
| 184 | Ventricular tachycardia (HP:0004756) | 1.67652889 |
| 185 | Malignant hyperthermia (HP:0002047) | 1.67556768 |
| 186 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.67191356 |
| 187 | Aplasia of the musculature (HP:0100854) | 1.65494831 |
| 188 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.63543639 |
| 189 | Loss of speech (HP:0002371) | 1.63491256 |
| 190 | Abnormality of the intrinsic pathway (HP:0010989) | 1.61867845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.56251594 |
| 2 | MAP3K13 | 4.24889587 |
| 3 | MAPK15 | 3.53856915 |
| 4 | IRAK4 | 3.45907781 |
| 5 | TAOK3 | 3.27527475 |
| 6 | TYK2 | 3.24256876 |
| 7 | OBSCN | 3.21485504 |
| 8 | EPHA2 | 3.18078031 |
| 9 | IKBKB | 2.64909138 |
| 10 | JAK3 | 2.62788282 |
| 11 | MST1R | 2.57774065 |
| 12 | RIPK4 | 2.41570224 |
| 13 | CHUK | 2.41421118 |
| 14 | IKBKE | 2.39842057 |
| 15 | TBK1 | 2.39105412 |
| 16 | EPHB1 | 2.32957888 |
| 17 | TTN | 2.31312687 |
| 18 | JAK1 | 2.23853814 |
| 19 | BMPR2 | 2.02837030 |
| 20 | MAP3K3 | 1.95173000 |
| 21 | ICK | 1.88671776 |
| 22 | EPHA3 | 1.80822642 |
| 23 | MAP2K3 | 1.71961105 |
| 24 | TRPM7 | 1.68595037 |
| 25 | NEK9 | 1.66327259 |
| 26 | FLT3 | 1.64270499 |
| 27 | PRKAA2 | 1.63427731 |
| 28 | FGFR4 | 1.57331815 |
| 29 | AKT3 | 1.55935006 |
| 30 | PIK3CG | 1.54163744 |
| 31 | MAP3K9 | 1.51405308 |
| 32 | MAPKAPK3 | 1.46395036 |
| 33 | EEF2K | 1.45032120 |
| 34 | ERN1 | 1.43419621 |
| 35 | PTK6 | 1.43384288 |
| 36 | FER | 1.43294050 |
| 37 | ACVR1B | 1.40602405 |
| 38 | JAK2 | 1.40557711 |
| 39 | KSR2 | 1.36107613 |
| 40 | FGFR3 | 1.33996525 |
| 41 | RIPK1 | 1.32190997 |
| 42 | MARK2 | 1.29821047 |
| 43 | INSRR | 1.28411569 |
| 44 | RET | 1.20507691 |
| 45 | FES | 1.19382582 |
| 46 | SIK2 | 1.19206027 |
| 47 | PHKG1 | 1.18992803 |
| 48 | PHKG2 | 1.18992803 |
| 49 | MOS | 1.12477566 |
| 50 | MET | 1.06800508 |
| 51 | CSK | 1.06664311 |
| 52 | CDK12 | 1.05824950 |
| 53 | LATS1 | 0.99212750 |
| 54 | KIT | 0.98436367 |
| 55 | PDK2 | 0.95785005 |
| 56 | ZAP70 | 0.94653405 |
| 57 | TNK2 | 0.92999520 |
| 58 | TAOK1 | 0.92558276 |
| 59 | CAMK1D | 0.92392985 |
| 60 | PKN1 | 0.90728229 |
| 61 | MST4 | 0.90061609 |
| 62 | CAMK1G | 0.89990252 |
| 63 | MAP2K6 | 0.88074268 |
| 64 | GRK1 | 0.85316698 |
| 65 | HIPK2 | 0.85238970 |
| 66 | MAP3K1 | 0.84399872 |
| 67 | CDK9 | 0.84195943 |
| 68 | MAPK12 | 0.82954611 |
| 69 | MTOR | 0.82414759 |
| 70 | IRAK1 | 0.81662930 |
| 71 | TIE1 | 0.79900787 |
| 72 | NLK | 0.79229127 |
| 73 | DDR2 | 0.77559500 |
| 74 | BTK | 0.76815043 |
| 75 | FRK | 0.76078777 |
| 76 | CSF1R | 0.75968058 |
| 77 | STK24 | 0.75871313 |
| 78 | SYK | 0.75771747 |
| 79 | MAP3K2 | 0.75763959 |
| 80 | SIK1 | 0.75316180 |
| 81 | BLK | 0.74471389 |
| 82 | SGK3 | 0.74214742 |
| 83 | IRAK3 | 0.73132350 |
| 84 | LMTK2 | 0.73003424 |
| 85 | HCK | 0.72325525 |
| 86 | EPHA4 | 0.71065161 |
| 87 | MELK | 0.68992229 |
| 88 | SGK1 | 0.67822448 |
| 89 | CAMKK1 | 0.67054201 |
| 90 | STK11 | 0.65421155 |
| 91 | MUSK | 0.63586053 |
| 92 | STK39 | 0.61639677 |
| 93 | WNK4 | 0.60238478 |
| 94 | DYRK1B | 0.59140562 |
| 95 | STK38L | 0.59098439 |
| 96 | TRIB3 | 0.58555710 |
| 97 | SGK2 | 0.57797808 |
| 98 | PKN2 | 0.56357264 |
| 99 | PDGFRB | 0.55603224 |
| 100 | PRKD2 | 0.55125921 |
| 101 | PDGFRA | 0.52545078 |
| 102 | PRKAA1 | 0.52068743 |
| 103 | DAPK2 | 0.51685275 |
| 104 | ERBB2 | 0.51233439 |
| 105 | PRKCZ | 0.50401781 |
| 106 | FGR | 0.49501730 |
| 107 | TEC | 0.49121597 |
| 108 | MATK | 0.48464737 |
| 109 | AKT1 | 0.48249095 |
| 110 | PRKCD | 0.47757107 |
| 111 | MAP3K6 | 0.47449849 |
| 112 | STK38 | 0.46482840 |
| 113 | MAP3K7 | 0.46225556 |
| 114 | PIM1 | 0.46050686 |
| 115 | CAMKK2 | 0.45692013 |
| 116 | MAP4K1 | 0.42922358 |
| 117 | PTK2 | 0.42525229 |
| 118 | MAPKAPK2 | 0.41479490 |
| 119 | IRAK2 | 0.41389108 |
| 120 | PTK2B | 0.40365215 |
| 121 | ABL1 | 0.40034052 |
| 122 | TGFBR2 | 0.39848994 |
| 123 | CAMK4 | 0.39713113 |
| 124 | LCK | 0.38986958 |
| 125 | MAPK7 | 0.38924900 |
| 126 | PIK3CA | 0.38718339 |
| 127 | DMPK | 0.38541232 |
| 128 | BMX | 0.38156723 |
| 129 | MARK3 | 0.37886481 |
| 130 | RPS6KA4 | 0.37394052 |
| 131 | PRKCQ | 0.37260669 |
| 132 | SGK494 | 0.37125967 |
| 133 | SGK223 | 0.37125967 |
| 134 | STK4 | 0.37091200 |
| 135 | RPS6KA1 | 0.36895321 |
| 136 | MAP2K2 | 0.36292053 |
| 137 | LRRK2 | 0.35819743 |
| 138 | EGFR | 0.35815958 |
| 139 | CDC42BPA | 0.35424206 |
| 140 | WNK1 | 0.34096675 |
| 141 | MYLK | 0.33878789 |
| 142 | STK3 | 0.33483964 |
| 143 | RAF1 | 0.33004311 |
| 144 | PDK1 | 0.32321001 |
| 145 | CDK6 | 0.32091841 |
| 146 | MAPK11 | 0.31774694 |
| 147 | YES1 | 0.30153945 |
| 148 | DYRK3 | 0.29852710 |
| 149 | PDPK1 | 0.27828011 |
| 150 | PAK6 | 0.26528324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.59724687 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.10818857 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.53839105 |
| 4 | Phototransduction_Homo sapiens_hsa04744 | 2.47543090 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.47316878 |
| 6 | Histidine metabolism_Homo sapiens_hsa00340 | 2.39105360 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.15251605 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.05273875 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.04885453 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99299758 |
| 11 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.94857040 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.91663510 |
| 13 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.91018659 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.87767511 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.83681608 |
| 16 | Circadian rhythm_Homo sapiens_hsa04710 | 1.75024554 |
| 17 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.73653464 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.70072402 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.68724486 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.58478604 |
| 21 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.58451194 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.55813428 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.55386840 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.50512382 |
| 25 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.42548710 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.40956643 |
| 27 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.39274425 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.38935608 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.38883150 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37863407 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.33646109 |
| 32 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.32511030 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.32113835 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.31157476 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30573029 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.26710656 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25067107 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.24965346 |
| 39 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.24696186 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.24383435 |
| 41 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.16873905 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.14883128 |
| 43 | Olfactory transduction_Homo sapiens_hsa04740 | 1.12718858 |
| 44 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.11776720 |
| 45 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11347321 |
| 46 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.10474127 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.10467209 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.09867788 |
| 49 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.09531872 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.08791843 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05585225 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.05459663 |
| 53 | Retinol metabolism_Homo sapiens_hsa00830 | 1.03378530 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.02561428 |
| 55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.02454554 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 1.01311786 |
| 57 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.98321636 |
| 58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95098654 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.93095754 |
| 60 | Legionellosis_Homo sapiens_hsa05134 | 0.92601768 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.90026483 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.89542363 |
| 63 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.89189848 |
| 64 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.85725625 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85159462 |
| 66 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.84201535 |
| 67 | Bile secretion_Homo sapiens_hsa04976 | 0.83589507 |
| 68 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.83059482 |
| 69 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.82646085 |
| 70 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.82338234 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81667793 |
| 72 | Morphine addiction_Homo sapiens_hsa05032 | 0.81419442 |
| 73 | Hepatitis C_Homo sapiens_hsa05160 | 0.80612895 |
| 74 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.80563362 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80299395 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79779435 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78657592 |
| 78 | Renin secretion_Homo sapiens_hsa04924 | 0.76595757 |
| 79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76486918 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.75889222 |
| 81 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.75726547 |
| 82 | Hepatitis B_Homo sapiens_hsa05161 | 0.74921569 |
| 83 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.74387674 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.74329154 |
| 85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72700774 |
| 86 | Shigellosis_Homo sapiens_hsa05131 | 0.71597757 |
| 87 | Adherens junction_Homo sapiens_hsa04520 | 0.70737747 |
| 88 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70467099 |
| 89 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68792263 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.67635046 |
| 91 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.67610807 |
| 92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66394695 |
| 93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66217795 |
| 94 | Asthma_Homo sapiens_hsa05310 | 0.65765531 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65408932 |
| 96 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65347708 |
| 97 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.63139530 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62940364 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61790735 |
| 100 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.60976217 |
| 101 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60938157 |
| 102 | Platelet activation_Homo sapiens_hsa04611 | 0.60790770 |
| 103 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60447239 |
| 104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60310966 |
| 105 | Lysosome_Homo sapiens_hsa04142 | 0.58969080 |
| 106 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58187713 |
| 107 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57949978 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57628883 |
| 109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56537513 |
| 110 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.56014916 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55761869 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55627607 |
| 113 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55207434 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54843390 |
| 115 | Tight junction_Homo sapiens_hsa04530 | 0.54473817 |
| 116 | Focal adhesion_Homo sapiens_hsa04510 | 0.54302095 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.53924894 |
| 118 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53360675 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52360530 |
| 120 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52279706 |
| 121 | GABAergic synapse_Homo sapiens_hsa04727 | 0.52211561 |
| 122 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.52139203 |
| 123 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51796515 |
| 124 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51200505 |
| 125 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50653655 |
| 126 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50512398 |
| 127 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.50389650 |
| 128 | Salmonella infection_Homo sapiens_hsa05132 | 0.50074844 |
| 129 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49705682 |
| 130 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49580881 |
| 131 | Malaria_Homo sapiens_hsa05144 | 0.49447054 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49117113 |
| 133 | Cocaine addiction_Homo sapiens_hsa05030 | 0.47622371 |
| 134 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47260320 |
| 135 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47199317 |
| 136 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47025187 |
| 137 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.45865871 |
| 138 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45835567 |
| 139 | Mineral absorption_Homo sapiens_hsa04978 | 0.44783038 |
| 140 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44693145 |
| 141 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.44593071 |
| 142 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.43850607 |
| 143 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.42953080 |
| 144 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42649754 |
| 145 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.42015613 |
| 146 | Circadian entrainment_Homo sapiens_hsa04713 | 0.41816211 |
| 147 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41255006 |
| 148 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40969558 |
| 149 | Other glycan degradation_Homo sapiens_hsa00511 | 0.40312755 |
| 150 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40056610 |
| 151 | Peroxisome_Homo sapiens_hsa04146 | 0.39842635 |

